VRBCF (Virbac) Accounts Payable : $183 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Virbac Accounts Payable?

Virbac's Accounts Payable for the quarter that ended in Dec. 2024 was $183 Mil.

Virbac's quarterly Accounts Payable declined from Dec. 2023 ($163 Mil) to Jun. 2024 ($161 Mil) but then increased from Jun. 2024 ($161 Mil) to Dec. 2024 ($183 Mil).

Virbac's annual Accounts Payable declined from Dec. 2022 ($165 Mil) to Dec. 2023 ($163 Mil) but then increased from Dec. 2023 ($163 Mil) to Dec. 2024 ($183 Mil).

Virbac Accounts Payable Historical Data

The historical data trend for Virbac's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Accounts Payable Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

128.05

144.18

165.06

163.17

182.80

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable	Get a 7-Day Free Trial															165.06	147.17	163.17	161.22	182.80

Virbac Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Virbac Accounts Payable Related Terms

Thank you for viewing the detailed overview of Virbac's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

VIRPp:UK 0NM7:UK VIRP:France V16:Germany

Address

13e rue LID - BP 27, Carros, FRA, 06511

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.